Pivotal bioVenture Partners CNS
Startup rounds since 2012 with a Pivotal bioVenture Partners CNS investor on the board, and the firm's own fund filings.
Raises
17
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Addition Therapeutics, Inc.$28M
- MapLight Therapeutics, Inc.$188M
- MapLight Therapeutics, Inc.$105M
- MapLight Therapeutics, Inc.$12M
- MapLight Therapeutics, Inc.$30M
- MapLight Therapeutics, Inc.$16M
- Alvarado Therapeutics, Inc.$5M
- Eargo, Inc.$51.2M
- Eargo, Inc.$54.5M
- Bolt Biotherapeutics, Inc.$10M
- Ra Pharmaceuticals, Inc.$29.2M
- Htg Molecular Diagnostics, IncUndisclosed
- Htg Molecular Diagnostics, IncUndisclosed
- Ceterix Orthopaedics, Inc.$31.3M
- Thesan Pharmaceuticals, Inc.$17.4M
- Htg Molecular Diagnostics, Inc$7.48M
- Altheos, Inc.$16.6M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2025 | 2 | 0 |
| 2023 | 1 | — |
| 2022 | 1 | — |
| 2021 | 1 | — |
| 2019 | 3 | — |
| 2018 | 1 | — |
| 2016 | 1 | — |
| 2015 | 2 | — |
| 2014 | 4 | — |
| 2012 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Pivotal bioVenture Partners CNS Fund I, L.P. | 23 Apr 2021 | Open-ended | — |
Listed because a Pivotal bioVenture Partners CNS fund's filing names a director of each company. A name match is not a verified identity.